AI Biotechnology LLC - 24 Mar 2025 SCHEDULE 13G Report for Surrozen, Inc. Common stock, par value $0.00001 per share (SRZN)

Filing Manager
AI Biotechnology LLC
Reporting Manager
AI Biotechnology LLC
Security
Surrozen, Inc. Common stock, par value $0.00001 per share
Symbol
SRZN
Shares outstanding
8,530,939 shares
Disclosed Ownership
844,563 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
31 Mar 2025, 16:01:03 UTC
Date of event
24 Mar 2025
SEC
View on sec.gov

Quoteable Key Fact

"AI Biotechnology LLC disclosed 9.9% ownership in Surrozen, Inc. Common stock, par value $0.00001 per share (SRZN) on 24 Mar 2025."

Quick Takeaways

  • AI Biotechnology LLC filed SCHEDULE 13G for Surrozen, Inc. Common stock, par value $0.00001 per share (SRZN).
  • Disclosed ownership: 9.9%.
  • Date of event: 24 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 31 Mar 2025, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
AI Biotechnology LLC 9.9% 844,563 0 844,563 /s/ Alejandro Moreno By: Access Industries Management, LLC, its manager; its Executive Vice President, General Counsel/Alejandro Moreno
Access Industries Holdings LLC 9.9% 844,563 0 844,563 /s/ Alejandro Moreno By: Access Industries Management, LLC, its manager; its Executive Vice President, General Counsel/Alejandro Moreno
Access Industries Management, LLC 9.9% 844,563 0 844,563 /s/ Alejandro Moreno Executive Vice President, General Counsel/Alejandro Moreno
Len Blavatnik 9.9% 844,563 0 844,563 */s/Alejandro Moreno By: Alejandro Moreno/Attorney-in-Fact